Thomas E. Witzig, Michael B. Tomblyn, Jamal G. Misleh, Ebenezer A. Kio, Robert M. Sharkey, William A. Wegener and David M. Goldenberg (2014) “Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphoma”, Haematologica. Pavia, Italy, 99(11), pp. 1738-1745. doi: 10.3324/haematol.2014.112110.